Cobra to boost gene therapy and CAR-T cpacity through £15m investment – BioPharma-Reporter.com
BioPharma-Reporter.com |
Cobra to boost gene therapy and CAR-T cpacity through £15m investment
BioPharma-Reporter.com The focus on gene therapy is in keeping with other investments and partnerships Cobra has established in recent years. Last June , for example, the CMO teamed up with UK-based Touchlight to test an AAV vector platform designed to make manufacturing … |
